VALIANT LABORATORIES
Back to Balance Sheet
|
VALIANT LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Total Current Liabilities | ₹119 Cr | ₹60 Cr | ₹29 Cr | ₹51 Cr |
What is the latest Total Current Liabilities ratio of VALIANT LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹119 Cr |
| Mar2025 | ₹60 Cr |
| Mar2024 | ₹29 Cr |
| Mar2023 | ₹51 Cr |
How is Total Current Liabilities of VALIANT LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹119 Cr | 100.36 | |
| Mar2025 | ₹60 Cr | 105.03 | |
| Mar2024 | ₹29 Cr | -42.68 | |
| Mar2023 | ₹51 Cr | - | |
Compare Total Current Liabilities of peers of VALIANT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VALIANT LABORATORIES | ₹572.1 Cr | -7.6% | -13.8% | 26.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,944.0 Cr | -2% | 6% | 9.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹294,962.0 Cr | -4% | 22.9% | 75.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,391.0 Cr | -1.8% | 1.8% | 21.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,267.0 Cr | -0.4% | 13.1% | 13.7% | Stock Analytics | |
| CIPLA | ₹112,620.0 Cr | -0.9% | 4.5% | -8% | Stock Analytics | |
VALIANT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VALIANT LABORATORIES | -7.6% |
-13.8% |
26.8% |
| SENSEX | 1.4% |
12.8% |
-1.7% |
You may also like the below Video Courses